SlideShare a Scribd company logo
1 of 33
PRESENTED BY
HIBA.C.H
RESHMA FATHIMA.K
FIRST YEAR M.PHARM
DEPT.OF.PHARMACEUTICS
2/25/2015 GRACE COLLEGE OF PHARMACY 1
CHARACTERIZATION OF RAW MATERIALS
 PHYSICAL CHARACTERIZATION
Bulk properties of API
Solid state properties of API
Intrinsic properties of API
 CHEMICAL CHARACTERIZATION
Confirmation of structure of API
Stability Analysis
2/25/2015 GRACE COLLEGE OF PHARMACY 2
2/25/2015 3
Confirmation of
structure of API
Stability/compatibility studies on
API/excipient mix ,Solubility
Dissolution
Changes on processing
Particlehabit/shape,
Particlesize/distribution
Density,Surface area,Flowability
Compaction
Polymorphism,Solvation,Crystallinity
Solubility,Partitioning/distribution
Melting/boiling points/sublimation
Dissolution
Nuclear magnetic resonance (NMR)
Mass spectroscopy,Elemental
analysis
API/excipient mix
Bulk properties of
API
Solid state
properties of API
Fundamental/intrinsic
properties of API
CONFIRMATION OF STRUCTURE OF API
 NMR SPECTROSCOPY
2/25/2015 GRACE COLLEGE OF PHARMACY 4
 IR SPECTROSCOPY
2/25/2015 GRACE COLLEGE OF PHARMACY 5
MASS SPECTROSCOPY
2/25/2015 GRACE COLLEGE OF PHARMACY 6
INTRINSIC PROPERTIES OF API
2/25/2015 GRACE COLLEGE OF PHARMACY 7
SOLUBILTY ANALYSIS INCLUDE
 Pka determination
 pH solubility profile
 Common ion effects
 Effect of temperature
 Solubilization
 Partition coefficient
 dissolution
2/25/2015 GRACE COLLEGE OF PHARMACY 8
Pka determinations
 Henderson hasselbalch equation
 Unionised drug absorbed from the GIT tract
 Pka value can be determined by variety of analytical methods.
 Spectral shifts by UV or visible spectroscopy
 Potentiometric titrations
2/25/2015 GRACE COLLEGE OF PHARMACY 9
Common ion effects
 common ion effect is defined as the suppression of the degree of
dissociation of a weak electrolyte containing a common ion.
2/25/2015 GRACE COLLEGE OF PHARMACY 10
Effect of temperature
2/25/2015 GRACE COLLEGE OF PHARMACY 11
DISSOLUTION
2/25/2015 GRACE COLLEGE OF PHARMACY 12
Dissolution is the process by which a solute forms
a solution in a solvent. The solute, in the case of solids, has
its crystalline structure disintegrated as separate ions,
atoms, and molecules form
2/25/2015 GRACE COLLEGE OF PHARMACY 13
PARTITION COEFFICIENT
2/25/2015 GRACE COLLEGE OF PHARMACY 14
MELTING POINT
 CAPILLARY MELTING
2/25/2015 GRACE COLLEGE OF PHARMACY 15
 HOT STAGE MICROSCOPY
2/25/2015 GRACE COLLEGE OF PHARMACY 16
SOLID STATE PROPERTIES
 POLYMORPHISM
 CRYSTALLINITY
 SOLVATION
2/25/2015 GRACE COLLEGE OF PHARMACY 17
DIFFERENTIAL SCANNING CALORIMETRY
2/25/2015 GRACE COLLEGE OF PHARMACY 18
DIFFERENTIAL THERMAL ANALYSIS
2/25/2015 GRACE COLLEGE OF PHARMACY 19
BULK PROPERTIES OF API
PARTICLE SIZE
PARTICLE SHAPE
SURFACE AREA
DENSITY
FLOW PROPERTIES
2/25/2015 GRACE COLLEGE OF PHARMACY 20
STABILITY ANALYSIS
 SOLUTION STABILITY
 SOLID STATE STABIULITY
2/25/2015 GRACE COLLEGE OF PHARMACY 21
STABILITYIN TOXICOLOGYFORMULATION
 Toxicology studies typically commence early in
development, it is often advisable to evaluate samples of
the toxicology preparation for stability and potential
homogeneity problems.
2/25/2015 22
Solutionstability
The primary objective of this phase of pre-formulation research is
identification of condition necessary to form a stable solution.
This study include-effect of pH, ionic strength, light, temperature and oxygen
2/25/2015 23
Solidstate stability
 Solid phase stability depends on several factors like temperature, pH, humidity,
hydrolysis, oxidation, etc
 For a new drug compound
Weighed sample are place in open screw cap vials and are exposed directly to light, temp,
humidity for 12weeks.
2/25/2015 24
INCOMPATIBILITY
ADAVANTAGE
 It helps to avoid surprise problems
TYPES
 Physical incompactibility
 Chemical incompactibility
 Therapeutic incompactibility
2/25/2015 25
Excipient interaction
 Drug –Excipient interactions
 Physical interaction
 chemical interaction
 Biopharmaceutical interaction
 Excipient –Excipient interactions
 Package –Excipient interaction
2/25/2015 26
PHYSICAL INTERACTION
 Tetracycline formed insoluble complex with calcium carbonate leading to
slower dissolution and decreased absorption.
 Formulation of chlorpromazine with polysorbate 80 and sodium lauryl
sulphate decreased membrane permeability of drug.
2/25/2015 GRACE COLLEGE OF PHARMACY 27
CHEMICAL INTERACTION
 Antibiotics, anaesthetics,barbiturates undergo in presence of water low or
high pH.
 Steroids, Vitamins, Antibiotics, Epinephrine, Aldehydes, Alcohols,
Phenols undergo oxidation reactions
2/25/2015 GRACE COLLEGE OF PHARMACY 28
BIOPHARMACEUTICAL INTERACTIONS
 Many of the excipients like sorbital, xylitol, have tendency to increase the
gastrointestinal motility thus reducing the time available for absorption of
drugs like metoprolol.
 Polyethylene glycol 400 also has influence on the absorption of ranitidine
2/25/2015 GRACE COLLEGE OF PHARMACY 29
EXCIPIENT-EXCIPIENT INTERACTIONS
 Acacia -Ethanol (95%) - Precipitate organic salts of Acacia
 Acacia- Ferric and other salts-Mucilage of acacia becomes gelatinous.
 Crosscarmellose Sodium- Hygroscopic excipients like Sorbitol Efficacy as
disintegrant reduced.
2/25/2015 GRACE COLLEGE OF PHARMACY 30
PACKAGE-EXCEPIENT INTERACTION
 Glass- Glass containers possess oxides of Boron, Sodium, Potassium,
Calcium, Iron and Magnesium which interact with formulation.
Alter physical and chemical stability of the formulation. E.g.:- sulphate salts
react with barium and calcium to form inorganic insoluble
salts.
2/25/2015 GRACE COLLEGE OF PHARMACY 31
 Plastic- Moisture uptake
Moisture uptake associated with disintegrants(STARCH) in tablet form
microcracks due to disintegrant swelling.
2/25/2015 GRACE COLLEGE OF PHARMACY 32
2/25/2015 GRACE COLLEGE OF PHARMACY 33

More Related Content

What's hot (20)

HSM
HSMHSM
HSM
 
NANOPARTICULATE DRUG DELIVERY SYSTEM
NANOPARTICULATE DRUG DELIVERY SYSTEMNANOPARTICULATE DRUG DELIVERY SYSTEM
NANOPARTICULATE DRUG DELIVERY SYSTEM
 
Phase separation
Phase separationPhase separation
Phase separation
 
TLC, thin layer chromatography
TLC, thin layer chromatographyTLC, thin layer chromatography
TLC, thin layer chromatography
 
Pharmaceutical industry and unit process
Pharmaceutical industry and unit processPharmaceutical industry and unit process
Pharmaceutical industry and unit process
 
Paper electrophoresis
Paper electrophoresis Paper electrophoresis
Paper electrophoresis
 
Drug targeting
Drug targetingDrug targeting
Drug targeting
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Capillary electrophoresis
Capillary electrophoresisCapillary electrophoresis
Capillary electrophoresis
 
Moving boundary electrophoresis mpat
Moving boundary electrophoresis mpatMoving boundary electrophoresis mpat
Moving boundary electrophoresis mpat
 
Good manufacturing practice (GMP)
Good manufacturing practice (GMP)Good manufacturing practice (GMP)
Good manufacturing practice (GMP)
 
Emulsifiers
EmulsifiersEmulsifiers
Emulsifiers
 
Ion exchange chromatography
Ion  exchange chromatographyIon  exchange chromatography
Ion exchange chromatography
 
Microbial transformation
Microbial transformationMicrobial transformation
Microbial transformation
 
Stability studies of drugs
Stability studies of drugsStability studies of drugs
Stability studies of drugs
 
Dendrimers
DendrimersDendrimers
Dendrimers
 
Size exclusion chromatography
Size exclusion chromatographySize exclusion chromatography
Size exclusion chromatography
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
Seminar on Preformulation studies
Seminar on Preformulation studiesSeminar on Preformulation studies
Seminar on Preformulation studies
 
Affinity chromatography ppt
Affinity chromatography pptAffinity chromatography ppt
Affinity chromatography ppt
 

Viewers also liked

Materials Characterization Technique Lecture Notes
Materials Characterization Technique Lecture NotesMaterials Characterization Technique Lecture Notes
Materials Characterization Technique Lecture NotesFellowBuddy.com
 
ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)Esam Yahya
 
Broad Spectrum Antibiotics
Broad Spectrum AntibioticsBroad Spectrum Antibiotics
Broad Spectrum Antibioticsmeducationdotnet
 
NYSAS Seminar LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...
NYSAS Seminar  LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...NYSAS Seminar  LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...
NYSAS Seminar LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...mzhou45
 
excipient incopatibilty 1
excipient incopatibilty 1excipient incopatibilty 1
excipient incopatibilty 1rina parveen
 
Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2
Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2
Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2Ajaz Hussain
 
Drug excipientinteractions
Drug excipientinteractionsDrug excipientinteractions
Drug excipientinteractionsceutics1315
 
Tetracyclines presentation
Tetracyclines presentationTetracyclines presentation
Tetracyclines presentationahmed khalifa
 
Fundamental of-product-development
Fundamental of-product-developmentFundamental of-product-development
Fundamental of-product-developmentfarwa hussain
 
Tableting technology
Tableting technologyTableting technology
Tableting technologyAmit Kundu
 
Layout for solid
Layout for solidLayout for solid
Layout for solidjigs2163
 
HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR
HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIRHPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR
HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIRmzhou45
 
SEMINAR ON COPROCESSED EXCIPIENTS 1
SEMINAR ON COPROCESSED EXCIPIENTS 1SEMINAR ON COPROCESSED EXCIPIENTS 1
SEMINAR ON COPROCESSED EXCIPIENTS 1NITIN KANWALE
 
Drug excepients compatability studies
Drug excepients compatability studiesDrug excepients compatability studies
Drug excepients compatability studieskinju19
 
factors affecting the selection of exepients
factors affecting the selection of exepientsfactors affecting the selection of exepients
factors affecting the selection of exepients11heena
 

Viewers also liked (20)

Drying Foods
Drying FoodsDrying Foods
Drying Foods
 
Materials Characterization Technique Lecture Notes
Materials Characterization Technique Lecture NotesMaterials Characterization Technique Lecture Notes
Materials Characterization Technique Lecture Notes
 
ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)
 
Broad Spectrum Antibiotics
Broad Spectrum AntibioticsBroad Spectrum Antibiotics
Broad Spectrum Antibiotics
 
NYSAS Seminar LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...
NYSAS Seminar  LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...NYSAS Seminar  LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...
NYSAS Seminar LC-IR To Characterize Polymeric Excipients In Pharmaceutical F...
 
excipient incopatibilty 1
excipient incopatibilty 1excipient incopatibilty 1
excipient incopatibilty 1
 
Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2
Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2
Excipient Knowledge Management Mumbai 12 March 2015 Part 1 & 2
 
Drug excipientinteractions
Drug excipientinteractionsDrug excipientinteractions
Drug excipientinteractions
 
Tableting & Scale up
Tableting & Scale upTableting & Scale up
Tableting & Scale up
 
Tetracyclines presentation
Tetracyclines presentationTetracyclines presentation
Tetracyclines presentation
 
Fundamental of-product-development
Fundamental of-product-developmentFundamental of-product-development
Fundamental of-product-development
 
Tablet and tablet press
Tablet and tablet pressTablet and tablet press
Tablet and tablet press
 
Tableting technology
Tableting technologyTableting technology
Tableting technology
 
Layout for solid
Layout for solidLayout for solid
Layout for solid
 
HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR
HPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIRHPLC2010  Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR
HPLC2010 Pharmaceutical Copolymer Excipient Characterization By GPC-FTIR
 
SEMINAR ON COPROCESSED EXCIPIENTS 1
SEMINAR ON COPROCESSED EXCIPIENTS 1SEMINAR ON COPROCESSED EXCIPIENTS 1
SEMINAR ON COPROCESSED EXCIPIENTS 1
 
Generic Drugs
Generic Drugs Generic Drugs
Generic Drugs
 
co-processed excipients ppt
co-processed excipients pptco-processed excipients ppt
co-processed excipients ppt
 
Drug excepients compatability studies
Drug excepients compatability studiesDrug excepients compatability studies
Drug excepients compatability studies
 
factors affecting the selection of exepients
factors affecting the selection of exepientsfactors affecting the selection of exepients
factors affecting the selection of exepients
 

Similar to Characterization of raw materials

Stability Of Peptides And Proteins
Stability Of Peptides And ProteinsStability Of Peptides And Proteins
Stability Of Peptides And ProteinsThilak Chandra
 
Formulation possibilities of weak bases
Formulation possibilities of weak basesFormulation possibilities of weak bases
Formulation possibilities of weak baseskovida munaga
 
Stability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.pptStability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.pptRavi Kumar G
 
Mechanism of drug degradation and protection
Mechanism of drug degradation and protectionMechanism of drug degradation and protection
Mechanism of drug degradation and protectionjyothiyagnam
 
Drug excipient compatibility
Drug excipient compatibilityDrug excipient compatibility
Drug excipient compatibilityRx Ayushi Patel
 
Stability Indicating HPLC Method Development A Review
Stability Indicating HPLC Method Development A ReviewStability Indicating HPLC Method Development A Review
Stability Indicating HPLC Method Development A Reviewijtsrd
 
Protein and peptide drug delivery
Protein and peptide drug deliveryProtein and peptide drug delivery
Protein and peptide drug deliveryHemantBansode2
 
Presentation final stability studies.pptx
Presentation final stability studies.pptxPresentation final stability studies.pptx
Presentation final stability studies.pptxHuma Hameed
 
Drug excipient compatibility
Drug excipient compatibilityDrug excipient compatibility
Drug excipient compatibilityPATEL NISARG
 
Co crystalization
Co crystalizationCo crystalization
Co crystalizationSujit Kale
 
final report fathima
final report fathimafinal report fathima
final report fathimaFathima P A
 
Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...Merck Life Sciences
 
Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...MilliporeSigma
 
Physiochemical factors influencing formulaon
Physiochemical factors influencing formulaonPhysiochemical factors influencing formulaon
Physiochemical factors influencing formulaonVishnu Mashroowala
 
use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...
use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...
use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...Kashif Haider
 

Similar to Characterization of raw materials (20)

Stability Of Peptides And Proteins
Stability Of Peptides And ProteinsStability Of Peptides And Proteins
Stability Of Peptides And Proteins
 
Formulation possibilities of weak bases
Formulation possibilities of weak basesFormulation possibilities of weak bases
Formulation possibilities of weak bases
 
Stability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.pptStability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.ppt
 
Module 1a.pptx
Module 1a.pptxModule 1a.pptx
Module 1a.pptx
 
Mechanism of drug degradation and protection
Mechanism of drug degradation and protectionMechanism of drug degradation and protection
Mechanism of drug degradation and protection
 
Drug excipient compatibility
Drug excipient compatibilityDrug excipient compatibility
Drug excipient compatibility
 
Seminar polymeric micelles
Seminar polymeric micellesSeminar polymeric micelles
Seminar polymeric micelles
 
Stability Indicating HPLC Method Development A Review
Stability Indicating HPLC Method Development A ReviewStability Indicating HPLC Method Development A Review
Stability Indicating HPLC Method Development A Review
 
Protein and peptide drug delivery
Protein and peptide drug deliveryProtein and peptide drug delivery
Protein and peptide drug delivery
 
Stability studies of drugs
Stability studies of drugsStability studies of drugs
Stability studies of drugs
 
tthiru pub 2.pdf
tthiru pub 2.pdftthiru pub 2.pdf
tthiru pub 2.pdf
 
Presentation final stability studies.pptx
Presentation final stability studies.pptxPresentation final stability studies.pptx
Presentation final stability studies.pptx
 
Drug excipient compatibility
Drug excipient compatibilityDrug excipient compatibility
Drug excipient compatibility
 
Co crystalization
Co crystalizationCo crystalization
Co crystalization
 
final report fathima
final report fathimafinal report fathima
final report fathima
 
Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...
 
Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...Amorphous formulations for bioavailability enhancement risks and opportunitie...
Amorphous formulations for bioavailability enhancement risks and opportunitie...
 
Physiochemical factors influencing formulaon
Physiochemical factors influencing formulaonPhysiochemical factors influencing formulaon
Physiochemical factors influencing formulaon
 
Drug stability
Drug stabilityDrug stability
Drug stability
 
use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...
use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...
use of omega-transaminase enzyme chemistry in the synthesis of JAK2 kinase in...
 

More from Reshma Fathima .K

Tablet coating defects and their remedies
Tablet coating defects and their remediesTablet coating defects and their remedies
Tablet coating defects and their remediesReshma Fathima .K
 
Teaching learning techniques for effective outcome based education
Teaching learning techniques for effective outcome based educationTeaching learning techniques for effective outcome based education
Teaching learning techniques for effective outcome based educationReshma Fathima .K
 
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONA SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONReshma Fathima .K
 
Bilayer Tablets of Aspirin and Atorvastatin
Bilayer Tablets of Aspirin and AtorvastatinBilayer Tablets of Aspirin and Atorvastatin
Bilayer Tablets of Aspirin and AtorvastatinReshma Fathima .K
 
FORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALFORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALReshma Fathima .K
 
Biopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical ManualBiopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical ManualReshma Fathima .K
 
Pharmacokinetics and plasma level time profile
Pharmacokinetics and plasma level time profilePharmacokinetics and plasma level time profile
Pharmacokinetics and plasma level time profileReshma Fathima .K
 

More from Reshma Fathima .K (20)

CAPSULES.pdf
CAPSULES.pdfCAPSULES.pdf
CAPSULES.pdf
 
PREFORMULATION STUDIES.pptx
PREFORMULATION STUDIES.pptxPREFORMULATION STUDIES.pptx
PREFORMULATION STUDIES.pptx
 
Prescription
PrescriptionPrescription
Prescription
 
Dosage forms
Dosage formsDosage forms
Dosage forms
 
Classification of powders
Classification of powdersClassification of powders
Classification of powders
 
Posology
PosologyPosology
Posology
 
Pharmaceutical calculations
Pharmaceutical calculationsPharmaceutical calculations
Pharmaceutical calculations
 
Pharmaceutics
PharmaceuticsPharmaceutics
Pharmaceutics
 
Tablet coating defects and their remedies
Tablet coating defects and their remediesTablet coating defects and their remedies
Tablet coating defects and their remedies
 
Pellets
PelletsPellets
Pellets
 
Parenteral products
Parenteral productsParenteral products
Parenteral products
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery system
 
Hypersensitivity reactions
Hypersensitivity reactionsHypersensitivity reactions
Hypersensitivity reactions
 
Teaching learning techniques for effective outcome based education
Teaching learning techniques for effective outcome based educationTeaching learning techniques for effective outcome based education
Teaching learning techniques for effective outcome based education
 
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONA SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
 
Bilayer Tablets of Aspirin and Atorvastatin
Bilayer Tablets of Aspirin and AtorvastatinBilayer Tablets of Aspirin and Atorvastatin
Bilayer Tablets of Aspirin and Atorvastatin
 
FORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALFORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUAL
 
Biopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical ManualBiopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical Manual
 
Bcs classification system
Bcs classification systemBcs classification system
Bcs classification system
 
Pharmacokinetics and plasma level time profile
Pharmacokinetics and plasma level time profilePharmacokinetics and plasma level time profile
Pharmacokinetics and plasma level time profile
 

Characterization of raw materials

  • 1. PRESENTED BY HIBA.C.H RESHMA FATHIMA.K FIRST YEAR M.PHARM DEPT.OF.PHARMACEUTICS 2/25/2015 GRACE COLLEGE OF PHARMACY 1
  • 2. CHARACTERIZATION OF RAW MATERIALS  PHYSICAL CHARACTERIZATION Bulk properties of API Solid state properties of API Intrinsic properties of API  CHEMICAL CHARACTERIZATION Confirmation of structure of API Stability Analysis 2/25/2015 GRACE COLLEGE OF PHARMACY 2
  • 3. 2/25/2015 3 Confirmation of structure of API Stability/compatibility studies on API/excipient mix ,Solubility Dissolution Changes on processing Particlehabit/shape, Particlesize/distribution Density,Surface area,Flowability Compaction Polymorphism,Solvation,Crystallinity Solubility,Partitioning/distribution Melting/boiling points/sublimation Dissolution Nuclear magnetic resonance (NMR) Mass spectroscopy,Elemental analysis API/excipient mix Bulk properties of API Solid state properties of API Fundamental/intrinsic properties of API
  • 4. CONFIRMATION OF STRUCTURE OF API  NMR SPECTROSCOPY 2/25/2015 GRACE COLLEGE OF PHARMACY 4
  • 5.  IR SPECTROSCOPY 2/25/2015 GRACE COLLEGE OF PHARMACY 5
  • 6. MASS SPECTROSCOPY 2/25/2015 GRACE COLLEGE OF PHARMACY 6
  • 7. INTRINSIC PROPERTIES OF API 2/25/2015 GRACE COLLEGE OF PHARMACY 7
  • 8. SOLUBILTY ANALYSIS INCLUDE  Pka determination  pH solubility profile  Common ion effects  Effect of temperature  Solubilization  Partition coefficient  dissolution 2/25/2015 GRACE COLLEGE OF PHARMACY 8
  • 9. Pka determinations  Henderson hasselbalch equation  Unionised drug absorbed from the GIT tract  Pka value can be determined by variety of analytical methods.  Spectral shifts by UV or visible spectroscopy  Potentiometric titrations 2/25/2015 GRACE COLLEGE OF PHARMACY 9
  • 10. Common ion effects  common ion effect is defined as the suppression of the degree of dissociation of a weak electrolyte containing a common ion. 2/25/2015 GRACE COLLEGE OF PHARMACY 10
  • 11. Effect of temperature 2/25/2015 GRACE COLLEGE OF PHARMACY 11
  • 12. DISSOLUTION 2/25/2015 GRACE COLLEGE OF PHARMACY 12 Dissolution is the process by which a solute forms a solution in a solvent. The solute, in the case of solids, has its crystalline structure disintegrated as separate ions, atoms, and molecules form
  • 13. 2/25/2015 GRACE COLLEGE OF PHARMACY 13
  • 14. PARTITION COEFFICIENT 2/25/2015 GRACE COLLEGE OF PHARMACY 14
  • 15. MELTING POINT  CAPILLARY MELTING 2/25/2015 GRACE COLLEGE OF PHARMACY 15
  • 16.  HOT STAGE MICROSCOPY 2/25/2015 GRACE COLLEGE OF PHARMACY 16
  • 17. SOLID STATE PROPERTIES  POLYMORPHISM  CRYSTALLINITY  SOLVATION 2/25/2015 GRACE COLLEGE OF PHARMACY 17
  • 18. DIFFERENTIAL SCANNING CALORIMETRY 2/25/2015 GRACE COLLEGE OF PHARMACY 18
  • 19. DIFFERENTIAL THERMAL ANALYSIS 2/25/2015 GRACE COLLEGE OF PHARMACY 19
  • 20. BULK PROPERTIES OF API PARTICLE SIZE PARTICLE SHAPE SURFACE AREA DENSITY FLOW PROPERTIES 2/25/2015 GRACE COLLEGE OF PHARMACY 20
  • 21. STABILITY ANALYSIS  SOLUTION STABILITY  SOLID STATE STABIULITY 2/25/2015 GRACE COLLEGE OF PHARMACY 21
  • 22. STABILITYIN TOXICOLOGYFORMULATION  Toxicology studies typically commence early in development, it is often advisable to evaluate samples of the toxicology preparation for stability and potential homogeneity problems. 2/25/2015 22
  • 23. Solutionstability The primary objective of this phase of pre-formulation research is identification of condition necessary to form a stable solution. This study include-effect of pH, ionic strength, light, temperature and oxygen 2/25/2015 23
  • 24. Solidstate stability  Solid phase stability depends on several factors like temperature, pH, humidity, hydrolysis, oxidation, etc  For a new drug compound Weighed sample are place in open screw cap vials and are exposed directly to light, temp, humidity for 12weeks. 2/25/2015 24
  • 25. INCOMPATIBILITY ADAVANTAGE  It helps to avoid surprise problems TYPES  Physical incompactibility  Chemical incompactibility  Therapeutic incompactibility 2/25/2015 25
  • 26. Excipient interaction  Drug –Excipient interactions  Physical interaction  chemical interaction  Biopharmaceutical interaction  Excipient –Excipient interactions  Package –Excipient interaction 2/25/2015 26
  • 27. PHYSICAL INTERACTION  Tetracycline formed insoluble complex with calcium carbonate leading to slower dissolution and decreased absorption.  Formulation of chlorpromazine with polysorbate 80 and sodium lauryl sulphate decreased membrane permeability of drug. 2/25/2015 GRACE COLLEGE OF PHARMACY 27
  • 28. CHEMICAL INTERACTION  Antibiotics, anaesthetics,barbiturates undergo in presence of water low or high pH.  Steroids, Vitamins, Antibiotics, Epinephrine, Aldehydes, Alcohols, Phenols undergo oxidation reactions 2/25/2015 GRACE COLLEGE OF PHARMACY 28
  • 29. BIOPHARMACEUTICAL INTERACTIONS  Many of the excipients like sorbital, xylitol, have tendency to increase the gastrointestinal motility thus reducing the time available for absorption of drugs like metoprolol.  Polyethylene glycol 400 also has influence on the absorption of ranitidine 2/25/2015 GRACE COLLEGE OF PHARMACY 29
  • 30. EXCIPIENT-EXCIPIENT INTERACTIONS  Acacia -Ethanol (95%) - Precipitate organic salts of Acacia  Acacia- Ferric and other salts-Mucilage of acacia becomes gelatinous.  Crosscarmellose Sodium- Hygroscopic excipients like Sorbitol Efficacy as disintegrant reduced. 2/25/2015 GRACE COLLEGE OF PHARMACY 30
  • 31. PACKAGE-EXCEPIENT INTERACTION  Glass- Glass containers possess oxides of Boron, Sodium, Potassium, Calcium, Iron and Magnesium which interact with formulation. Alter physical and chemical stability of the formulation. E.g.:- sulphate salts react with barium and calcium to form inorganic insoluble salts. 2/25/2015 GRACE COLLEGE OF PHARMACY 31
  • 32.  Plastic- Moisture uptake Moisture uptake associated with disintegrants(STARCH) in tablet form microcracks due to disintegrant swelling. 2/25/2015 GRACE COLLEGE OF PHARMACY 32
  • 33. 2/25/2015 GRACE COLLEGE OF PHARMACY 33